Researchers identified a reducing reagent-resistant transferrin receptor 1 (TfR1) dimer that forms during lipid peroxidation and can be detected in cells and blood-borne extracellular vesicles as a ferroptosis marker. The study presents a molecular “fingerprint” for ferroptosis that could improve how labs measure ferroptosis biology across preclinical and translational contexts. Because ferroptosis is implicated in multiple disease pathways and emerging therapeutics, having a more specific marker could reduce reliance on indirect proxies like lipid ROS readouts. The reported detectability in tissues and in extracellular vesicles suggests potential for blood-based assays that track ferroptosis states. Key next steps are validation across broader conditions, determining assay robustness under different sample handling workflows, and mapping marker levels to therapeutic response in ferroptosis-targeting interventions.